193 related articles for article (PubMed ID: 18518829)
1. Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine.
Burger JL; Cape SP; Braun CS; McAdams DH; Best JA; Bhagwat P; Pathak P; Rebits LG; Sievers RE
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):25-34. PubMed ID: 18518829
[TBL] [Abstract][Full Text] [Related]
2. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
[TBL] [Abstract][Full Text] [Related]
3. Dry powder measles vaccine: particle deposition, virus replication, and immune response in cotton rats following inhalation.
Kisich KO; Higgins MP; Park I; Cape SP; Lindsay L; Bennett DJ; Winston S; Searles J; Sievers RE
Vaccine; 2011 Jan; 29(5):905-12. PubMed ID: 20974303
[TBL] [Abstract][Full Text] [Related]
4. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry.
Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763
[TBL] [Abstract][Full Text] [Related]
5. Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
Bouchard A; Jovanović N; Hofland GW; Jiskoot W; Mendes E; Crommelin DJ; Witkamp GJ
Eur J Pharm Biopharm; 2008 Mar; 68(3):781-94. PubMed ID: 17702554
[TBL] [Abstract][Full Text] [Related]
6. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
Wanning S; Süverkrüp R; Lamprecht A
Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
[TBL] [Abstract][Full Text] [Related]
7. A powder formulation of measles vaccine for aerosol delivery.
LiCalsi C; Maniaci MJ; Christensen T; Phillips E; Ward GH; Witham C
Vaccine; 2001 Mar; 19(17-19):2629-36. PubMed ID: 11257402
[TBL] [Abstract][Full Text] [Related]
8. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay.
Schlehuber LD; McFadyen IJ; Shu Y; Carignan J; Duprex WP; Forsyth WR; Ho JH; Kitsos CM; Lee GY; Levinson DA; Lucier SC; Moore CB; Nguyen NT; Ramos J; Weinstock BA; Zhang J; Monagle JA; Gardner CR; Alvarez JC
Vaccine; 2011 Jul; 29(31):5031-9. PubMed ID: 21616113
[TBL] [Abstract][Full Text] [Related]
9. The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process.
Poursina N; Vatanara A; Rouini MR; Gilani K; Najafabadi AR
Acta Pharm; 2016 Jun; 66(2):207-18. PubMed ID: 27279064
[TBL] [Abstract][Full Text] [Related]
10. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
Kasper JC; Schaffert D; Ogris M; Wagner E; Friess W
J Control Release; 2011 May; 151(3):246-55. PubMed ID: 21223985
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
Razavi Rohani SS; Abnous K; Tafaghodi M
Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
13. Stable sugar-based protein formulations by supercritical fluid drying.
Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851
[TBL] [Abstract][Full Text] [Related]
14. Heat-stable measles vaccine produced by spray drying.
Ohtake S; Martin RA; Yee L; Chen D; Kristensen DD; Lechuga-Ballesteros D; Truong-Le V
Vaccine; 2010 Feb; 28(5):1275-84. PubMed ID: 19944152
[TBL] [Abstract][Full Text] [Related]
15. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
16. Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry.
Corbanie EA; Remon JP; Van Reeth K; Landman WJ; van Eck JH; Vervaet C
Vaccine; 2007 Nov; 25(49):8306-17. PubMed ID: 17977632
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared spectroscopic evaluation of lyophilized viral vaccine formulations.
Hansen L; Beer TD; Pieters S; Heyden YV; Vervaet C; Remon JP; Montenez JP; Daoussi R
Biotechnol Prog; 2013; 29(6):1573-86. PubMed ID: 24014045
[TBL] [Abstract][Full Text] [Related]
18. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
19. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
Schüle S; Friess W; Bechtold-Peters K; Garidel P
Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
[TBL] [Abstract][Full Text] [Related]
20. Stability of yellow fever vaccine.
Monath TP
Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
